MINNEAPOLIS, Feb. 22, 2012 (GLOBE NEWSWIRE) -- OnPoint Medical Diagnostics (OTCQB:ONMD) announces a symbolic move from product development into commercialization with an agreement signed by Abbott Northwestern Hospital to use OnPoint's cloud-based technologies to automate its MRI quality assurance process.
"We're excited to be at this stage in our core product's life cycle," states William Cavanaugh, CEO of OnPoint. "While our MRI quality assurance software has been in use at a number of medical facilities nationally, this agreement with Abbott Northwestern Hospital is symbolic of how far we've come as a young medical device software company. It is great to be delivering a solution that makes our customers more efficient and effective in operating their medical imaging quality control programs."
As the largest hospital in the Twin Cities, Abbott Northwestern is recognized nationally and locally for its exceptional expertise and care. Each year, the hospital serves more than 200,000 patients and their families from across the Twin Cities and Upper Midwest.
"We've already experienced the benefits of OnPoint's MRI quality assurance system," states Holly Mazis, MRI Supervisor at Abbott Northwestern Hospital. "MRI quality control used to be a labor-intensive process, consisting of manual measurements and maintaining paper log books. Now with OnPoint's technology, results are calculated in seconds, which is a significant time saver for my staff. In addition, by using OnPoint's trending and alerts, we have proactively called in service, saving the hospital thousands of dollars in unplanned downtime."
"Ultimately," says Mazis, "it is about patient care. OnPoint helps to ensure all of our MRI scanners are producing the highest quality medical images possible, every single day."
OnPoint provides a comprehensive quality control program that exceeds the gold standard of accreditation from the American College of Radiology. It can detect gradual degradation in image quality and identify problems before they impact clinical results. The system includes a web-enabled image viewer, real-time dashboards, analytics and trending that are fully deployed in the cloud providing access to any authorized user with a web browser.
OnPoint's MRI quality assurance software is available on a month-to-month basis or as an annual subscription, and offers a 30-day free trial to all new customers. For more information, visit www.onpointmd.com.
About OnPoint Medical Diagnostics
OnPoint is dedicated to leveraging technology and intelligent systems to assist the global healthcare industry in delivering the highest quality medical images possible – safely, consistently and efficiently. OnPoint's enterprise quality assurance solution is deployed in the cloud and delivered in a SaaS framework, which provides anytime, anywhere access to the technology. The company's flagship product for MRI is focused on automating the quality control measures required for accreditation by the American College of Radiology, with real-time dashboards, analytics and trending to make sure scanners are providing the best possible images of patients. For more information, visit www.onpointmd.com.
Notice Regarding Forward-Looking Statements
In addition to historical facts or statements of current condition, this press release contains forward-looking statements within the meaning of the "Safe Harbor" provisions of The Private Securities Litigation Reform Act of 1995. Forward-looking statements provide the company's current expectations or forecasts of future events. The company's performance and financial results could differ materially from those reflected in these forward-looking statements due to risks and uncertainties that could cause our results to differ materially from those expressed or implied by such forward-looking statements, including, but not limited to: our ability to react to trends and challenges in our business and the markets in which we operate; our ability to anticipate market needs or develop new or enhanced products to meet those needs; the adoption rate of our products; our ability to establish and maintain successful relationships with our collaboration partners; our ability to compete in our industry; fluctuations in demand, sales and prices for our products and services; our ability to protect our intellectual property rights; our ability to limit liability for claims against our predecessor or as a result of our restructuring; general political, economic and market conditions and events; and other risks and uncertainties described more fully described in our documents filed with or furnished to the Securities and Exchange Commission. Given these risks and uncertainties, any or all of these forward-looking statements may prove to be incorrect. The company undertakes no obligation to update publicly any forward-looking statement.